The drug Eylea is indicated for adult patients for the treatment of:
neovascular (wet) age-related macular degeneration (wet AMD);
decreased visual acuity caused by macular edema due to occlusion of the retinal veins (central vein (CRVO) or its branches (BRVO));
decreased visual acuity caused by diabetic macular edema (DME).
Active ingredient: aflibercept
Storage temperature 2-8 degrees